AbbVie to bolster immunity illness drug pipeline with Landos buy

cafead

Administrator
Staff member
  • cafead   Mar 25, 2024 at 11:52: AM
via AbbVie will buy drug developer Landos Biopharma for up to $212 million as the Humira-maker aims to expand its pipeline of medicines to treat immune system-related illnesses, the companies said on Monday.

article source